<DOC>
	<DOCNO>NCT02674685</DOCNO>
	<brief_summary>Examine safety effectiveness Vfend [ voriconazole ] prophylaxix use general clinical practice .</brief_summary>
	<brief_title>Vfend Special Investigation For Prophylaxis</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<criteria>Patients undergo HSCT ( Hematopoietic Stem Cell Transplantation ) . Patients previously enrol study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>